Related Experiment Video
Updated: Mar 9, 2026
10:14
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
4.3K
OUTER RETINAL LAYER CHANGES AFTER DEXAMETHASONE IMPLANT FOR CENTRAL RETINAL VEIN OCCLUSION
Maurizio Battaglia Parodi1, Pierluigi Iacono, Matteo Scaramuzzi
1*Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy; and †G.B. Bietti Foundation for Study and Research in Ophthalmology, IRCCS, Rome, Italy.
Retina (Philadelphia, Pa.)
|December 29, 2016
Summary
Dexamethasone implants effectively treat macular edema in central retinal vein occlusion (CRVO) patients. Early outer retinal layer integrity on OCT predicts better visual recovery after treatment.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Medical Imaging
Background:
- Macular edema secondary to central retinal vein occlusion (CRVO) significantly impairs vision.
- Spectral-domain optical coherence tomography (SD-OCT) is crucial for assessing retinal structural changes.
Purpose of the Study:
- To analyze outer retinal layer changes visualized by SD-OCT following dexamethasone implant treatment for CRVO-related macular edema.
- To correlate baseline outer retinal layer status with visual outcomes.
Main Methods:
- A prospective study included 30 patients with CRVO-related macular edema, categorized by age and ischemia.
- Patients received dexamethasone implants, with retreatments based on macular edema detection.
- Outer retinal layers (external limiting membrane, ellipsoid zone, retinal pigment epithelium) were assessed via SD-OCT at baseline and 12 months.
Main Results:
- Significant recovery of outer retinal layers was observed across all CRVO subgroups after treatment.
- The non-ischemic CRVO group younger than 50 (<50-niCRVO) showed the greatest structural improvement.
- Best-corrected visual acuity improved significantly (0.85 to 0.45), but only in eyes with present or disrupted outer retinal layers at baseline.
Conclusions:
- Dexamethasone implants are effective in resolving macular edema in all CRVO subtypes.
- Preserved or disrupted outer retinal layers on baseline SD-OCT are essential for achieving beneficial visual outcomes post-treatment.
